Are there any changes in the #endocannabinoid system in #Alzheimer’s Disease (AD)? This is the question @tc3consortium.bsky.social Trainee Alumna, Anna Pees, Member, Neil Vasdev, & team set out to answer using PET imaging in a mouse model of AD. @uoftmedicine.bsky.social www.thno.org/v15p3368.htm
Sex- and age-specific sensitivities of the endocannabinoid system in Alzheimer's disease revealed by PET imaging with [18F]FMPEP-d2 and [18F]MAGL-2102
Sex- and age-specific sensitivities of the endocannabinoid system in Alzheimer's disease revealed by PET imaging with [<sup>18</sup>F]FMPEP-<i>d</i><sub>2</sub> and [<sup>18</sup>F]MAGL-2102
thno.org